Urigen N.A. Completes Reverse Merger With Valentis, Inc. (VLTS)
7/16/2007 11:44:37 AM
More...
|
Urigen N.A. Completes Shareholder Meeting
6/29/2007 12:57:16 PM
More...
|
Urigen N.A. Board Member Resigns
6/19/2007 2:59:16 AM
More...
|
Urigen N.A. and S. Grant Mulholland, M.D. to Collaborate on URG301 Drug Development Project for Overactive Bladder
6/13/2007 2:03:01 PM
More...
|
Valentis, Inc. (VLTS) Announces Effectiveness of Registration Statement for the Proposed Merger With Urigen N.A.
6/12/2007 2:24:36 PM
More...
|
Valentis, Inc. (VLTS) And Urigen N.A. Announce The Filing Of A Registration Statement Relating To Their Proposed Merger Transaction
2/7/2007 3:11:45 PM
More...
|
Urigen N.A. Appoints Dennis Giesing, PhD As Director Of Product Development
1/8/2007 9:32:36 AM
More...
|
Urigen N.A. Engages Sichenzia Ross Friedman Ference LLP
12/21/2006 1:09:14 PM
More...
|
Urigen N.A. Appoints Terry M. Nida To Chief Operating Officer
11/29/2006 12:03:00 PM
More...
|
Urigen N.A. Announces Phase 2 Results For U101 In Chronic Pelvic Pain
10/31/2006 11:09:55 AM
More...
|